What's new

Human medicines European public assessment report (EPAR): Piqray, alpelisib, Date of authorisation: 27/07/2020, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Piqray, alpelisib, Date of authorisation: 27/07/2020, Revision: 15, Status: Authorised

Feb 12, 2025 - 14:14
 0
Human medicines European public assessment report (EPAR): Piqray, alpelisib, Date of authorisation: 27/07/2020, Revision: 15, Status: Authorised
Human medicines European public assessment report (EPAR): Piqray, alpelisib, Date of authorisation: 27/07/2020, Revision: 15, Status: Authorised
Read More

Tags:

Previous Article

Biogen enlists Royalty for pursuit of lupus crown, securing $250M to fund phase ...

Next Article

Opinion/decision on a Paediatric investigation plan (PIP): Vaxzevria (previously...

Related Posts

Human medicines European public assessment report (EPAR): Saxenda, liraglutide, Date of authorisation: 23/03/2015, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 20, 2025  0

European Medicines Agency’s data protection notice rega...

Feb 18, 2025  0

Human medicines European public assessment report (EPAR): Ponvory, ponesimod, Date of authorisation: 19/05/2021, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0